Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique.

MLA

De Luca, Andrea, et al. “Accumulation of HIV-1 Drug Resistance in Patients on a Standard Thymidine Analogue-Based First Line Antiretroviral Therapy after Virological Failure: Implications for the Activity of next-Line Regimens from a Longitudinal Study in Mozambique.” BMC Infectious Diseases, vol. 17, no. 1, Sept. 2017, p. 605. EBSCOhost, https://doi.org/10.1186/s12879-017-2709-x.

APA

De Luca, A., Sidumo, Z. J., Zanelli, G., Magid, N. A., Luhanga, R., Brambilla, D., Liotta, G., Mancinelli, S., Marazzi, M. C., Palombi, L., & Ceffa, S. (2017). Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique. BMC Infectious Diseases, 17(1), 605. https://doi.org/10.1186/s12879-017-2709-x

Chicago

De Luca, Andrea, Zita Jorge Sidumo, Giacomo Zanelli, Noorjehan Abdul Magid, Richard Luhanga, Davide Brambilla, Giuseppe Liotta, et al. 2017. “Accumulation of HIV-1 Drug Resistance in Patients on a Standard Thymidine Analogue-Based First Line Antiretroviral Therapy after Virological Failure: Implications for the Activity of next-Line Regimens from a Longitudinal Study in Mozambique.” BMC Infectious Diseases 17 (1): 605. doi:10.1186/s12879-017-2709-x.